Abeona Therapeutics (ABEO) Tops Q2 EPS by 209c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of $1.71, $2.09 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Texas AG Paxton announces ongoing investigation into Carnival over data breach
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ